Asthma Clinical Trials in Barcelona
12 recruitingBarcelona, Spain
Showing 1–12 of 12 trials
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
Asthma
Teva Branded Pharmaceutical Products R&D LLC2,700 enrolled393 locationsNCT06052267
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Moderate to Severe Asthma
Incyte Corporation240 enrolled84 locationsNCT05851443
Recruiting
Phase 3
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
Asthma
AstraZeneca200 enrolled112 locationsNCT05692180
Recruiting
Phase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Asthma
AstraZeneca540 enrolled208 locationsNCT06932263
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
AstraZeneca231 enrolled142 locationsNCT06023589
Recruiting
Oscillometry and Machine Learning Approaches
Asthma COPD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau50 enrolled1 locationNCT07447596
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
Asthma
Novartis Pharmaceuticals200 enrolled61 locationsNCT05562466
Recruiting
Phase 2
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Asthma
Novartis Pharmaceuticals42 enrolled23 locationsNCT05222529
Recruiting
Phase 3
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled27 locationsNCT04898283
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.150 enrolled32 locationsNCT04435990
Recruiting
Phase 3
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled32 locationsNCT04891237